Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials

Ankeet S. Bhatt, Muthiah Vaduganathan, Brian L. Claggett, Ian J. Kulac, Inder S. Anand, Akshay S. Desai, James C. Fang, Adrian F. Hernandez, Pardeep S. Jhund, Mikhail N. Kosiborod, Marc S. Sabatine, Sanjiv J. Shah, Orly Vardeny, John J.V. McMurray, Scott D. Solomon, Thomas A. Gaziano

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials'. Together they form a unique fingerprint.

Medicine & Life Sciences